Importance of Cord Blood Banking

The first cord blood transplant was performed in 1988. Since then, more than 8,000 transplants have occurred.Families know that there is only one opportunity – at birth – to collect these genetically unique stem cells and if not taken, the cord blood is simply discarded. The opportunity for expectant families to collect and store their newborn’s umbilical cord blood stem cells has only been widely available since late 1995.Currently, thousands of parents are taking advantage of this once-in-a-lifetime opportunity. New treatments with cord blood focus on regenerative medicine – where doctors use stem cells to repair damaged tissues and organs in the body.

Cord Blood preservation is viewed it as a type of “biological insurance” – because these stem cells may be lifesaving to their family, as there are many dieseases cured by cord blood.Our baby’s cord blood may offer a lifetime of protection:

• Ready availability of a treatment method using Cord Blood when needed, and faster treatment is always better.
• For treating cancers and blood disorders in transplant medicine, having the family’s own cord blood available has many advantage as it reduces complications.
• The baby’s cord blood may be used to treat many diseases including leukemia, other cancers, and blood disorders.
• Regenerative medicine therapies using cord blood, the child’s own stem cells are required.
• Potential to treat conditions that have no cure today – like juvenile diabetes and brain injury.
• Ready availability of a treatment method using Cord Blood when needed, and faster treatment is always better.

Some families have more defined risk factors, but most families bank for the security of knowing the health benefits that stem cells may someday offer their children, themselves, or other family members.

Is Cord blood America going to be one of the hot stocks of tomorrow?

Recently Cord Blood America in Las Vegas has received lot of news coverage and is traded publically since 2003.
CBAI, moving toward achieving its goal of becoming a globally dominant stem cell storage company, recently signed a deal licensing its umbilical cord blood technology to AXM Pharma Inc., a China pharmaceutical and nutraceutical company.

They are actually located on Helm Drive in Las Vegas and currently hold the record for the largest cryogenic storage facility in the world. Currently US, Russia, China, Japan, and Europe are the leaders in Cryogenic technology.

Cryogenic pertains to liquefied gases, ie, helium, nitrogen, CO2, which are all inert and extremely cold, ie. -270 deg. Celsius. Others are reactive, LP, Hydrogen.